BridgeBio Pharma, Inc.BBIONASDAQ
Loading
Direct costs attributable to producing goods sold
3Y CAGR
+101.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
8.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $28.27M | +629.1% |
| 2024 | $3.88M | +58.5% |
| 2023 | $2.45M | -28.8% |
| 2022 | $3.43M | +10.3% |
| 2021 | $3.11M | - |
| 2020 | $0.00 | -100.0% |
| 2019 | $2.50M | - |
| 2018 | $0.00 | -100.0% |
| 2017 | $260000.00 | - |